Healio

FDA clears first ‘rapid diagnostic’ hepatitis C RNA test for point-of-care settings

Please provide your email address to receive an email when new articles are posted on . The FDA granted marketing authorization for Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first ...
Healio

To initiate same-day hepatitis C testing and treatment, hepatitis B status must be known

Please provide your email address to receive an email when new articles are posted on . The FDA’s recent authorization of a rapid, point-of-care test to diagnose current hepatitis C virus infection is ...
FOX31 Denver

FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test

Test Enables Single-Visit Testing and Treatment for Hepatitis C SILVER SPRING, Md., June 27, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration granted marketing authorization to ...
FierceBiotech

FDA clears its first fingerstick hepatitis C diagnostic, enabling test-to-treat approach

The FDA has greenlit its first point-of-care diagnostic test for hepatitis C, capable of using only a fingerstick blood sample, in a bid to quickly connect patients with antiviral drugs. “Despite the ...
Renal & Urology News

FDA Clears Point-of-Care Test to Detect Hepatitis C Virus

Credit: Cepheid. The Xpert HCV test delivers results in about an hour. The Food and Drug Administration (FDA) has granted marketing authorization to Xpert ® HCV, a point-of-care hepatitis C virus (HCV ...
Forbes

A Cure For Hepatitis C: Diagnosis And Direct-Acting Antiviral Drugs

In previous articles of this series, we’ve discussed several aspects of the hepatitis C virus including the nature of the infection and its distribution both globally and in the United States. Most ...
Medscape

Hepatitis C Viral Load Fluctuates Without Treatment

Fluctuations in circulating hepatitis C virus RNA could be "clinically meaningful" in a substantial number of patients with chronic infection, and could influence the best time to prescribe antiviral ...